Meet the blood diseases team 

Specialist Multi-Disciplinary Team (MDT)

A specialist MDT is a team of our professionals who will be caring for and supporting you. This team consists of experts in different areas of medicine and care such as doctors, nurses, dietitians, speech and language therapists, physiotherapists and occupational therapists.

It is important that you understand what your treatment involves.

Please feel free to ask questions to clarify anything about your care plan that is not clear. We will do our utmost to answer your questions clearly and honestly.

We will give you written information about your diagnosis and treatment to support the discussions you will have with members of the team. We will explain any aspects of the written information you may need help with.

We recommend that you write down any questions you wish to ask us before your appointment and we will answer them when we see you. We also encourage you to bring a relative or friend with you to clinic, as they can help you remember what has been discussed as well as offer you support.

  • Clinical Nurse Specialists (CNS) in Cancer Care

    Clinical Nurse Specialists (CNS) have specialist training, advanced clinical skills and extensive experience in treating patients with your type of cancer. They offer advice and support throughout your diagnosis, treatment and follow-up.

    Your CNS may also act as your ‘key-worker’ during your treatment, which means they are a consistent point of contact for you, your family and any professionals involved in your care. They can be contacted between 09:00 and 17:00, Monday to Friday (excluding Bank Holidays) via the Haematology Telephone Line on 020 3447 7359. For out of hours advice (emergency calls at evenings, weekends and Bank Holidays) call 0785 2220 900.

  • Research Team

    If your treatment is part of a clinical trial as described above, you will also be supported by a CNS for haematology research.


    Sufyan Achhala, Clinical Trials Practitioner

    Sufyan works with multiple myeloma patients. He is actively involved in the coordination of patient care whilst on clinical trials. He works on a number of Phase 3 studies both commercial and non-commercial, including those patients newly diagnosed and at relapse.


    Miranda Avery, Clinical Research Practitioner

    Miranda AveryMiranda identifies recruits and supports patients taking part in lymphoma clinical trials. Miranda is part of a small team of staff working to support the large portfolio of trials available at UCLH to patients with different types of lymphoma.

    Miranda supports junior members of the clinical trials team with their personal and professional development. At present Miranda spends half of her time working with the NIHR Clinical Research Network, North Thames to develop and improve cancer research practices at hospital trusts within North / Central London and the bordering counties.


    Alex Brownsdon, Senior Research Nurse

    Alex is a senior research nurse working in the Haematology Clinical Trials Unit at UCLH. She joined the team in October 2015 as part of the Trust’s merger with the Royal Free Hospital’s haematology service.

    Prior to her current role, Alex has worked within a range of specialties including paediatric and young adult, oncology research. The senior research nurse role encompasses many different responsibilities and involves being a trial co-ordinator, a clinical nurse and patient advocate and a role model to patients and staff.

    Alex has a particular interest in the patient experience and long-term survivorship following cancer treatment.

    "It is a privilege to be working within one of the largest haematology services in Europe and I am proud to be part of a team that offers high quality and pioneering research to the patients who are treated at the UCLH hospitals."


    Georgina Dean, Leukaemia Research Nurse

    Georgina is a research nurse within the acute leukaemia team. She began working in the Cancer Clinical Trials Unit (CCTU) at the beginning of 2016. Previously, she was a staff nurse on the haematology inpatient wards. Her time on the wards gave her great insight in to the patient experience of undergoing intensive haematological cancer treatments.

    "The most rewarding part of my job is knowing that I am involved in helping improve the future treatment for acute leukaemia and experience of patients with the disease."


    Laura Favero, Leukaemia Research Nurse

    Laura Favero is a leukaemia research nurse who specialises in chronic leukaemia. She is also involved in the research of new treatments for acute leukaemia and multiple myeloma.

    “The most rewarding part of my role at UCLH is caring for patients through their cancer journey and being able to offer patients new and pioneering treatment.”


    Craig Jones, Clinical Trials Practitioner and Lymphoma Team Lead

    CraigJones

    Craig works as a senior Clinical Trial Practitioner and leads the lymphoma research team within the Haematology clinical trials unit. This team supports a large portfolio of trials available to UCLH patients with different types of lymphoma.

    Craig supports junior members of the clinical trials team with their personal and professional development while working to develop the portfolio of trials available at UCLH. As part of the multi-disciplinary team Craig is a key contact for patients participating in research and is integrated into the lymphoma multidisciplinary team.

    “UCLH is a forward thinking and leading NHS trust for clinical research. We are striving to make the UK a competitive and innovative place to do research. I am committed to improving patient care and changing practise through evidence based medicine.”


    Janet Lyons-Lewis, Senior Clinical Trials Practitioner

    Janet Lyons-LewisJanet works as a senior Clinical Trials Practitioner in the Haematology Clinical Trials Unit. She has been working in this unit since 2010, and has covered a broad range of roles and disease areas. She is currently the lead co-ordinator for early phase studies, which include trials for patients with lymphoma, myeloma, chronic leukaemia and myelofibrosis. The Clinical Trial Practitioner role allows science graduates the opportunity to have hands-on role in a research setting, a role historically performed by research nurses.

    “UCLH is regarded as a leader in the field of research and I am proud to be a part of a team that drives drug development, whilst maintaining patient safety and providing holistic care.”


    Thomas Taylor, Clinical Trials Practitioner

    Thomas works as a clinical trial practitioner recruiting patients into bone marrow transplant and gene/cell therapy clinical trials. Bone marrow transplantation often offers the only curative treatment for patients with haematological malignancies so it’s very important to try and improve the success rate though researching new transplant techniques. There have also been very encouraging results in gene and cell therapy approaches such as CAR-T cell treatments. These trials are early phase and offer an incredibly exciting treatment option to chemotherapy refractory or relapsed patients at UCLH.


    Devanshi Pandit, Clinical Trials Practitioner

    Devanshi is a clinical trials practitioner specialising in multiple myeloma and Waldenströms macroglobulinaemia. She has been working in haematology trials since 2012 and has worked on a wide range of trials from early phase to late phase. She is involved in commercial and academic trials some of which are national and international. As a trials practitioner, Devanshi acts as patient advocate and participates in decisions concerning the treatment of patients on trial in accordance to the study and where appropriate, provides direct patient care.

    "It’s a privilege to be working with such a huge multidisciplinary healthcare team in identifying and meeting the needs of the patients and their family during various stages of their disease. It's rewarding to know that I can help make a difference".


  • Macmillan Cancer Support Worker

    Macmillan Support Workers provide one-to-one patient support, advice and guidance, and links patients to the Macmillan Support and Information Service at UCLH.

  • Haematology Pharmacist

    Haematology pharmacists work alongside the team and will help advise you on any medications or chemotherapy prescribed for you. You will meet them in the clinic, Day Care or on the ward.
  • Other MDT Members

    There are other specialists such as physiotherapists, occupational therapists, social workers, counsellors and dietitians who are part of the extended MDT. You may be referred to these specialists if appropriate.

 Consultants

Dr Kirit Ardeshna, Divisional Clinical Director for Cancer and Consultant Haemato-oncologist

Dr Kirit Ardeshna is the lead blood diseases clinician at UCLH. He specialises in treating patients with haematological malignancies and has a particular interest in non-Hodgkin's and Hodgkin's lymphoma. He is also an honorary senior lecturer at UCL.

“The most rewarding part of my role at UCLH is curing some patients and helping others managing their long-term conditions so they can lead good quality lives.”

Full consultant profile

Dr Stephanie Baldeweg, Consultant Physician

Dr Baldeweg is a Consultant Physician in Diabetes and Endocrinology at University College London Hospital and Honorary Senior Lecturer in the Department of Medicine at UCL. She graduated from Humboldt University, Berlin in 1990 and undertook her Specialist Training in London.

Dr Baldeweg is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease, and is now looking to perform research in endocrine disorders secondary to POEMS syndrome.

Dr Francisca Caimari, Clinical Fellow

Dr Caimari is a Clinical Fellow in Diabetes and Endocrinology at University College London Hospital. She finished her clinical training in Barcelona and moved to London in 2014 to undertake a PhD in the field of pituitary disease. After a 2-year fellowship in research, she is currently working as a clinical fellow, with a special interest in the impact of endocrine disorders caused by POEMS.

Aviva Cerner

Aviva is a haematology Clinical Nurse Specialist focusing on myeloma and plasma cell disorders. She has worked as a haematology nurse at University College London Hospital for 15 years and before that in oncology and neurosurgery. During her time as a haematology nurse, she has developed a special interest in POEMS syndrome and the wide-ranging effects it has on the patient and their family and carers. She works with the team in the monthly POEMS clinic.

Prof Ronjon Chakraverty, Consultant Haematologist

Prof Ronjon Chakraverty

Professor Chakraverty is an attending physician on the Bone Marrow Transplantation programme that runs at the Royal Free London and University College London Hospitals.

Full consultant profile

Dr Hannah Cohen, Consultant Haematologist

Dr Hannah Cohen

Dr Hannah Cohen is a Consultant Haematologist at UCLH. She is trust clinical lead for anticoagulation and venous thromboembolism; and clinical lead for the thrombosis and haemostasis service to Women’s Health at UCLH.

Full consultant profile

Dr Kate Cwynarski, Consultant Haematologist

Dr Cwynarski's interests are in lymphoma and chronic lymphocytic leukaemia with specialist interests in HIV-related lymphoma, primary CNS lymphoma, HTLV1-associated lymphoproliferative disease. She has been involved in writing lymphoma guidelines for BCSH and BHIVA.

Full consultant profile

Dr Shirley D’Sa, Consultant Haematologist

Dr Shirley D'Sa

Dr D’Sa specialises in the treatment of Waldenströms macroglobulinaemia, paraproteinaemic neuropathies, Bing-Neel syndrome, POEMS syndrome and Myeloma and Solitary Bone Plasmacytoma. She is also an honorary Senior Lecturer at the UCL Cancer Institute.

“UCLH is an enabling and forward-facing institution with excellent academic links. It is a pleasure to be able to work in close knit clinical teams with medical, nursing colleagues and support staff who collectively strive to work for the patients. I have had the good fortune to meet and look after patients with relatively rare conditions, many of whom are motivated to work together to improve the outlook for Waldenströms patients through the work of a self-styled doctor-patient charity, WMUK (www.wmuk.org.uk)“

Full consultant profile

Dr Emma Drasar, Consultant Haematologist

Dr Emma Drasar

Emma Drasar is a consultant haematologist working between UCLH and the Whittington NHS trust. She trained at St Barts and the Royal London School of Medicine, University of London and qualified in 2001 and was awarded MRCP in 2006. She completed her haematology training at King's College Hospital being awarded FRCPath in 2015.

Dr Drasar was appointed Clinical Lecturer in Sickle Cell Disease at King’s from 2009 to 2013. During this time she was awarded a PhD based on research into markers of severity and predictors of organ dysfunction in sickle cell disease and in 2013 was awarded the Early Stage Investigator prize from the British Society of Haematology.

Full consultant profile

Dr Perla Eleftheriou, Consultant Haematologist

Dr Perla Eleftheriou

Dr Perla Eleftheriou is clinical governance lead of the Red Cell Haematology department at UCH. Her area of special interest is Red Cell Disorders, which include haemoglobinopathies and rare anaemias, as well as polycythaemias and iron overload disorders. Dr Eleftheriou teaches haematology at the London School of Hygiene and Tropical Medicine and is a visiting lecturer of haematology at the Nicosia Medical School in Cyprus. Dr Eleftheriou also serves as clinical/scientific adviser to Thalassaemia International Federation and is a member of the UK Thalassaemia Society.

Full consultant profile

Prof Adele Fielding, Consultant Haematologist

Prof Adele Fielding

Adele Fielding is Professor of Haematology at UCL with a clinical practice at UCLH, where she works within the leukaemia service. Her primary expertise is in acute lymphoblastic leukaemia. She chairs the UK National Cancer Research Institute Adult ALL subgroup. As a clinician scientist, she is heavily involved in the UK's clinical trials programme for ALL and am Chief Investigator of UKALL14 and UKALL60+, the UK's frontline academically-initiated trials for ALL. Her research lab program takes advantage of the opportunity to do translational work arising from these trials.

Full consultant profile

Dr David Foldes, Specialist Registrar

David is a haematology Specialist Registrar with an interest in paraproteinaemias. During his previous training he worked at the NHNN and gained experience in the management of peripheral neuropathies, and POEMS unifies those broad interests. He helped to set up the POEMS database and is keen to apply its use for both patient care and research.

Dr Rajeev Gupta, Consultant Haematologist

Dr Rajeev Gupta

Dr Gupta is a consultant haematologist specialising in diagnostic haematology and treating patients with acute leukaemia admitted as inpatients. He is also a senior lecturer in haematology at the UCL Cancer Institute and his areas of research interest are haematopoietic stem cell biology and understanding cell state transitions in haematopoietic stem cells and how they impact cell fate decision making. 

“The most rewarding part of my work at UCLH providing a high quality 'state of the art' diagnostic facility for the haematological oncology service at UCLH is the most rewarding part of my work at UCLH”

Full consultant profile

Dr Rachael Hough, Consultant Haematologist

Dr Racheal Hough

Dr Rachael Hough is a consultant haematologist at UCLH and honorary consultant haematologist at Great Ormond Street Hospital. Her specialist areas include blood diseases in teenagers, haematological malignancy and haemopoietic stem cell transplantation. Dr Hough is an honorary senior lecturer at UCL and is currently involved in research into cord blood transplantation and acute lymphoblastic leukaemia in teenagers and young adults.

Full consultant profile

Dr Derralynn Hughes, Consultant Haematologist

Dr Derralynn Hughes

Dr Hughes studied medicine at Oxford University and has joined UCLH as a consultant haematologist.

Dr Stephen Keddie, Specialist Registrar

Stephen is a neurology Specialist Registrar working in North London with an interest in peripheral nerve disorders. He received a 3-year research grant by the Association of British Neurologists to take time out of training to study POEMS syndrome pathogenesis, in particular the neuropathy it causes. His work will form the basis of a PhD.

Prof Asim Khwaja, Consultant Haematologist

Prof Asim Khwaja

Professor Asim Khwaja is a consultant haematologist at UCLH and professor of Haematology at the UCL Cancer Institute. He is lead clinician for adult acute leukaemias at UCLH specialising in the treatment of acute myeloid and lymphoid leukaemias. He is a member of the National Cancer Research Institute Haematological Oncology Clinical Studies Group and of the Cancer Research UK New Agents Committee. His area of particular research interest is studying the messages that cause blood cancer cells to grow out of control and in developing new targeted therapies that block these signals.

Full consultant profile

Dr Panagiotis Kottaridis, Consultant Haematologist

Dr Panagiotis Kottaridis

Dr Panos Kottaridis is a consultant haematologist specialising in leukaemia and bone marrow transplantation.

Dr Charalampia Kyriakou, Consultant Haematologist

Dr Charalampia Kyriakou

Dr Kyriakou is a consultant haematologist. She is actively involved on national and international clinical trials in haematological diseases.

Dr Jonathan Lambert, Consultant Haemato-oncologist

Dr Jonathan Lambert

Dr Jonathan Lambert is a consultant haemato-oncologist at UCLH. He specialises in treating Myeloproliferative  neoplasms and  lymphoma.He is the clinical haematology undergraduate teaching programme at UCLH and lists his research interests as myeloproliferative neoplasms and lymphoma (particular interest in functional imaging in lymphoma).

“The most rewarding part of my work at UCLH is being  part of a dynamic, modern team with expertise in looking after people with even the most complex haematological cancers, and being able to provide cutting-edge anti-cancer therapies to patients who can benefit from them. I also greatly enjoy teaching students and other doctors”

Full consultant profile

Prof David Linch, Consultant Haematologist and Director of the UCL/UCLH Biomedical Research Centre Cancer Programme

Prof David Linch

Prof David Linch is a consultant haematologist and director of the University College London / UCLH Biomedical Research Centre Cancer Programme. He specialises in lymphoma, and focuses his research on the pathogenesis of acute myeloid leukaemia and the development of new therapeutic approaches in lymphoproliferative disorders.

Full consultant profile

Dr Michael Lunn, Consultant Neurologist and Clinical Lead

Dr Lunn is a Consultant Neurologist and Clinical Lead in Neuroimmunology and Honorary Senior Lecturer at the National Hospital for Neurology and Neurosurgery.

His specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and haematological neuropathy causing conditions such as paraproteinaemic neuropathies and POEMS syndrome. 

Full consultant profile.

Prof Stephen MacKinnnon, Consultant Haematologist

Prof Stephen MacKinnnon

Professor Mackinnon leads the bone marrow and stem cell program at University College London. He attended medical school at the University of Glasgow. He subsequently trained in Internal Medicine and Haemato-oncology in Glasgow. This was followed by a transplant fellowship at the Hammersmith Hospital in London where he developed an interest in graft-versus-leukaemia reactions.

In 1995 he returned to London to his current position. In recent years he has developed an interest novel conditioning regimens. Current research interests include adoptive immunotherapy and immune reconstitution following allogeneic stem cell transplantation. The program has world class transplant outcomes for patients with leukaemia and lymphoma.

Full consultant profile

Dr Marc Mansour, Consultant Haematologist

Dr Marc Mansour

Dr Marc Mansour is an honorary consultant haematologist at UCLH and research group leader at the UCL Cancer Institute. He undertook his medical degree at the University of Edinburgh, medical training at King's College London and UCLH, followed by an MRC Clinical Research Training PhDship in the laboratory of Professors David Linch and Rosemary Gale at UCL, where he studied Notch signalling in acute leukaemia. He was funded by the Kay Kendell Leukemia Research Fund to undertake a travelling fellowship at Harvard Medical School and Dana-Farber Cancer Institute in Boston, USA. He was awarded the HMS Claudia Adams Barr Innovative Research award, and was a Harvard Medical School faculty member from 2012-2014. He is currently funded as a Bennett Senior Fellow by Bloodwise.

His research has focused on two aggressive haematological malignancies - T-cell acute lymphoblastic leukaemia (T-ALL) and acute myeloid leukaemia (AML). He has published extensively on the biology of acute leukaemia, authoring papers in Science, Nature, Nature Cell Biology, JCI, ELife, JCO and J Ex Med. His clinical interest is in ALL, AML and myelodysplasia (MDS).

Full consultant profile

Dr Christopher McNamara, Consultant Haematologist

Dr Christopher McNamara is a consultant haematologist with an interest in general haematology and haematological malignancies. His specialty interest is in lymphoma and he has published extensively on this subject.

Full consultant profile

Prof Atul Mehta, Consultant Haematologist

Prof Atul Mehta

Professor Mehta is a consultant haematologist with a special interest in myeloma. His academic interest is in rare lysosomal diseases and their treatment.

Dr Sajir Mohamedbhai, Honorary Consultant Haematologist

Dr Sajir Mohamedbhai

Sajir Mohamedbhai is an honorary consultant haematologist. He is a member of the lymphoma team at UCLH and runs a general haematology clinic. He is involved in recruiting patients into clinical trials in lymphoma.

“I enjoy being part of a highly dedicated and friendly team, where everyone is committed to going the extra mile for our patients. It is particularly rewarding to see the positive impact this has on our patients' lives”

Full consultant profile

Prof Emma Morris, Professor of Clinical Cell and Gene Therapy and Consultant Haematologist

Prof Emma Morris

Professor Emma Morris is a consultant haematologist at UCLH. Her clinical interest is in the field of haematopoietic stem cell transplantation. She is currently secretary of the Clinical Trials Committee of the British Society for Blood and Marrow Transplantation and on the Editorial Board of the British Journal for Haematology.

Full consultant profile

Prof Amit Nathwani, Professor of Haematology and Consultant Haematologist

Dr Amit Nathwani

Professor Amit Nathwani specialises in treating haematological cancer including chronic lymphocytic leukaemia.

"My primary research interest is to use gene transfer technology to develop novel therapies for NHS priority areas such as cancer and chronic disorders. We hope to develop a novel immunotherapy approach for CLL."

Full consultant profile

Dr Beth Payne, Honorary Consultant Haematologist

Dr Beth Payne specialises in the treatment of MDS and Bone Marrow Failure. She is also a Senior Clinical Researcher funded by the Wellcome Trust and The Leuka John Goldman Fellowship for future Science and runs a research laboratory studying the mechanisms of disease in bone marrow failure and myelodysplastic syndromes and is also working to develop novel therapeutics.

Her areas of research interest are MDS and Bone Marrow Failure, especially Diamond-Blackfan Anaemia and 5q-syndrome MDS. She has also been involved in research projects in acute lymphoblastic leukaemia, acute myeloid leukaemias with CEBPA mutations and biology and management of familial MDS/leukaemia and bone marrow failure.

“The most rewarding part of my work is getting to know and treat patients and working with an amazing team of doctors, nurses and other support workers”

Full consultant profile

Prof Karl Peggs, Transplant Science and Cancer Immunology

Dr Karl Peggs

Professor Karl Peggs is an honorary consultant in haematology and transplantation at UCLH. His research interests include immune reconstitution, pathogen-specific adoptive cellular therapies, and regulatory checkpoint-directed immunotherapeutics. Dr Peggs is a member of the Leukaemia and Lymphoma Research Clinical Trials Committee, a Trustee of the Teens Unite charity, and has contributed to several international working parties on infectious complications and relapse following stem cell transplantation. He is Chief Investigator for four UKCRN national studies investigating transplantation in Hodgkin Lymphoma and cellular therapies for cytomegalovirus. Dr Peggs has also been the senior lecturer in Stem Cell Transplantation and Immunotherapy at UCL since 2003.

Full consultant profile

Dr Rakesh Popat, Consultant Haematologist

Dr Rakesh Popat

Dr Rakesh Popat is a consultant haematologist who specialises in multiple myeloma and Phase 1 and 2 clinical trials for haematological cancers. His main area of research interest is the clinical development of new drugs for the treatment of haematological cancers. Dr Popat is also an honorary clinical senior lecturer at the UCL Cancer Institute, the National Institute for Health Research North Thames Clinical Research Network Haematology (Cancer) lead, and a member of both the National Cancer Research Institute myeloma sub-group and the Myleloma UK clinical trials steering group.

“The most rewarding part of my work at UCLH is being able to offer new potential treatments to those that need them.”

Full consultant profile

Professor John Porter, Consultant Haematologist

Prof John Porter

Professor John Porter is a consultant haematologist at UCLH, professor of Haematology at UCL and head of the joint Red Cell Unit for UCLH and Whittington Hospitals. His main clinical and research fields have been the treatments of thalassaemia and sickle cell disorders, with particular reference to iron overload in these conditions. Professor Porter has published more than 150 peer-reviewed articles, and has made numerous contributions to books, as well as clinical guidelines and other medical articles.

Full consultant profile

Dr Martin Pule

Dr Martin Pule

Dr Martin Pule as well as being a senior Lecturer at University College London, holds an honorary consultant post as a clinical haematologist at UCLH. He is the principle investigator in an open clinical study of engineered T-cells at UCLH.

Full consultant profile

Dr Neil Rabin

Dr Neil Rabin

Dr Neil Rabin runs the myeloma trials clinic, is responsible for patients referred up for autologous stem cell transplantation and participates in the general myeloma service at UCLH. Dr Rabin is principal and co-investigator on several studies evaluating new treatments for myeloma, both at diagnosis and in relapse. He investigated novel therapies to treat myeloma bone disease for his PhD, and continues to have an active interest in this area.

Full consultant profile

Dr Marie Scully, Consultant Haematologist

Dr Marie Scully

Dr Scully was appointed as a consultant at UCLH in 2007, with an interest in haemostasis and thrombosis. She is clinical lead for haematopathology and blood transfusion at UCLH. She is also the lead for TTP and associated TMAs, including aHUS. UCLH is a specialist centre for TTP.

Full consultant profile

Dr Mallika Sekhar, Consultant Haematologist

Dr Mallika Sekhar

Dr Mallika Sekhar is a consultant haematologist and honorary senior lecturer at UCL specialising in myeloproliferative diseases across UCLH and Royal Free hospitals with a special interest in patients with vascular thrombosis and myeloproliferative diseases. Her other specialist areas include acute leukaemia and transfusion medicine. She has been involved in writing guidelines on MPD for BCSH.

Full consultant profile

Dr Farrukh Shah

Dr Farrukh Shah

Dr Farrukh Shah was awarded her MD thesis for research in iron chelation at University College London. She has already built an international reputation in the management of iron problems and of thalassaemia

Full consultant profile

Dr Mari Thomas, Consultant Haematologist

Dr Mari Thomas is a new Haematology consultant joining the Thrombosis team at UCLH. She recently completed a PhD at UCL looking into the role of antibodies in TTP. As part of the TTP team, she manages both inpatients and outpatients with TTP and other thrombotic microangiopathies, such as atypical HUS. Her other areas of interest include venous thromboembolism in cancer patients.

Dr Thomas is starting a new clinic for cancer VTE in the UCLH MacMillan Cancer Centre. She also specialises in obstetric haematology, running a joint antenatal clinic for high-risk pregnancies with Dr Cohen and obstetric colleagues. She acts as liaison between the transfusion laboratory and the Fetal Medicine Unit for women with red cell alloantibodies in pregnancy.

"The most rewarding part of my work is working with a great team and seeing our research findings translated into better outcomes for patients."

Full consultant profile

Dr Kirsty Thomson, Consultant Haematologist

Dr Kirsty Thomson

Dr Kirsty Thomson is a consultant haematologist specialising in bone marrow transplant (BMT) and haematopoietic stem cell transplantation (HSCT).

Full consultant profile

Dr Sara Trompeter, Consultant Haematologist

Dr Sara Trompeter

Dr Sara Trompeter is a consultant haematologist and paediatric haematologist. She specialises in red cell and iron disorders in children and adults, including sickle cell, thalassaemia, enzymopathies, membranopathies and haemochromatosis. Sara also works with the transplant team to develop the haemoglobinopathy stem cell transplant programme for adolescents.

Her main research interest is transfusion in sickle cell disease and thalassaemia, and she also has an academic role with NHS Blood and Transplant to develop and evidence base for transfusion in haemoglobinopathies.

“The most rewarding part of my role at UCLH is that I am constantly interacting with brilliant collaborative colleagues who can inspire and motivate you. The atmosphere at UCLH generated by staff, encourages innovation and improvement in treatments for patients. The junior doctors are also of an extremely high standard.”

Full consultant profile

Dr Andres Virchis, Consultant Haematologist

Dr Andres Virchis

Dr Andres Virchis holds a weekly lymphoma autograft clinic and attends the myeloma clinic on alternate weeks. He is also joint Haematology Tumour Board chair for the North London Cancer Network. Dr Virchis’s specialist interests are Hodgkin’s and non-Hodgkin’s lymphoma, and haematological stem cell transplantation.

Full consultant profile

Dr Ashutosh Wechalekar, Consultant Haematologist

Dr Ashutosh Wechalekar

Dr Wechalekar is a academic consultant haematologist specialing in plasma cell dyscrasias (multiple myeloma and AL amyloidosis). He is Reader in Medicine and Haematology at UCL. He is a chief investigator on national and international trials in the respective areas and has published extensivey on plasma cell disorders.

His academic and clinical interests are focused on amyloidosis and multiple myeloma.

Dr John-Paul Westwood, Consultant Haematologist

Dr John-Paul Westwood specialises in Haemostasis and Thrombosis, including Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombocytopenia (ITP), and bleeding disorders. He also work as a Transfusion consultant. His research intrests are in non-malignant haematology, including TTP and ITP. I am also involved in supporting clinical trials in these disease areas.

“The most rewarding part of my work at UCLH is treating patients with varied and often challenging diseases in the field of haemostasis and thrombosis”

Full consultant profile

Dr Wai Keong Wong, Consultant Haematologist

Dr Wai Keong Wong is a Consultant Haematologist specialising in Bone Marrow Diagnostics and clinical IT and informatics. He lists his specialist area of research as the application of Informatics and IT to drive quality improvement.

"The most rewarding part of UCLH is working in a constantly changing and dynamic environment within an organisation with true vision and ambition. It also helps that everyone is very nice and friendly."

Prof Kwee Yong, Multiple Myeloma Clinical Lead

Prof Kwee Yong

Professor Kwee Yong is the clinical and academic lead in multiple myeloma at UCLH and the North London Cancer Network (NLCN), and wrote the NLCN guideline for the management of this cancer.

Full consultant profile

 Clinical Nurse Specialists (CNS)

Stephen Rowley, Senior Matron

Stephen Rowley
Stephen manages the haematology nursing services. He has been a cancer nurse for nearly 20 years working in paediatric and adult haematology and bone marrow transplantation. He is Clinical Director for the Association for Safe Aseptic Practice, Chair of the British Haematology Nurses Society and Chair of the UCLH Haematology Cancer Care Charity.
 
“My job is to help ensure we provide a robust nursing service as patients rely on nursing expertise for safe high quality care.”

Syeda Ahmed, Clinical Nurse Specialist for Myeloproliferative Neoplasms (MPN)

Syeda is a clinical nurse specialist in MPN. She has experience in haematology in both inpatients and outpatients as a ward nurse and ward manager. She joined the clinical nurse specialists in 2014 at the Royal Free Hospital to work with MPN patients. Syeda’s experience within haematology includes symptom management, chemotherapy, bone marrow transplant and acutely unwell patients.

Syeda has undertaken further studies and holds a BSc in haemato-oncology from Kings College London.

“The most rewarding part of my job is making a difference to the patients and their family’s lives by supporting them through their diagnosis and beyond.”

Claire Barton, Lymphoma Association Clinical Nurse Specialist

Claire Barton
Claire works with people of all ages diagnosed with different types of lymphoma. She is the lymphoma lead for young adults and has always worked in cancer care. She regularly reviews and writes patient information for the Lymphoma Association and other lymphoma charities. Claire is building upon her expertise by studying for a Masters’ degree focusing on cancer care.

“I am passionate about delivering age-appropriate care to patients”

Jane Bowley, Bone Marrow Transplant Clinical Nurse Specialist

Jane Bowley

Jane specialises in caring for patients who need allogeneic and autologous stem cell transplants. 

“The most rewarding part of my role is supporting patients through their transplant and being involved in their long term follow up”

Simon Clare, Clinical Nurse Specialist

Simon Clare

Simon is the practice development lead for haematology, leading a team of clinical practice facilitators (CPF) providing specialised clinical education and continuing practice development for nursing staff in haematology. His research focuses on improving aseptic technique, clinical competencies and practice education.

“The most rewarding part of my role at UCLH is collaborating with such a dedicated and effective team of healthcare professionals to improve the clinical competency of our nursing team”

Alicia Cooper, Stem Cell Transplant Clinical Nurse Specialist

Alicia Cooper

Alicia co-ordinates autologous stem cell transplants for patients with a variety of blood cancers. She becomes involved in the patients care at the point of referral for a stem cell transplant. Her role is to ensure patients have an efficient pathway to transplant and provides support before, during and post-transplant to facilitate a good patient experience.

"The most rewarding part of my job is seeing patients post-transplant when they have fully recovered and are back to enjoying life – free of chemotherapy and multiple hospital visits!”

Flora Dangwa, Leukaemia Clinical Nurse Specialist

Flora is a clinical nurse specialist working with patients diagnosed with acute leukaemia and related myelodysplastic syndromes. She has experience working in haematology as a clinical nurse specialist and clinical research nurse. She holds a diploma in Cancer Nursing from The Royal Marsden as well as an MSc Advanced Nursing Practice – Cancer from King’s College.

Flora’s areas of special interest include patient advocacy, voluntary work supporting leukaemia and myeloma charities.

“The most rewarding part of my job is improving patient experience by working with patients, their families and carers so that they feel informed, supported and cared for at all times.”

Juan de Cruz, Myeloma Clinical Nurse Specialist

Juan de Cruz
Juan has worked in cancer care since qualifying as an adult nurse and specialising in cancer nursing and chemotherapy. He is bringing his extensive knowledge and experience of caring for inpatients to provide excellent care for patients treated on a day care basis. 

“Communicating effectively and building relationships with all my patients is vital. I am passionate about providing care that is patient centred”

Shari Denovan, Bone Marrow Transplant Clinical Nurse Manager

Shari Denovan

Shari Denovan is UCLH’s bone marrow transplant clinical nurse manager. Her areas of research interest include sexuality and counselling.

“The most rewarding part of my role at UCLH is educating patients, and arming them with information and tools to make adjustments to their lives post bone marrow transplant"

Jackie Horder, Donor Clinical Nurse Specialist

Jackie Horder

Jackie deals exclusively with the care of all the allogeneic bone marrow/peripheral stem cell transplant donors. This covers individuals who are either a blood relative of the patient, or an unrelated volunteer via a registry. She maintains strong links with both the Anthony Nolan Trust and Great Ormond Street Hospital for Children.

“The most rewarding part of my role is to educate and support individuals through a process that can be daunting and completely unfamiliar, and to make them feel comfortable and secure”

Bernadette Hylton, Haemoglobinopathies Clinical Nurse Specialist

Bernadette Hylton

Bernadette specialises in sickle cell disease, thalassaemia and conditions associated with red blood cells. She currently doing research in health related quality of life in sickle cell disease as part of her Masters degree.

“The most enjoyable part of my job is getting to know my patients and having a positive impact on their life”.

Clair Isworth, Myelodysplasia and Acute Leukaemia Clinical Nurse Specialist

Clair Isworth
Clair specialises in acute leukaemias, with a special interest in MyeloDysplastic syndromes (MDS) and aplastic anaemia (AA) and has spent her nursing career focusing on the care of cancer patients of all ages. She is currently undertaking her Masters degree and is researching innovation for excellence and service improvement, which is aimed at improving the patient experience through cancer treatment pathways.

“The most rewarding part of my role is to be able to implement change, and be part of leading a service and dedicated team that evolves and continues to strive for excellence for our patients and their outcomes”.

Siobhan McGuckin, TTP Clinical Nurse Specialist

Siobhan McGuckin

Siobhan McGuckin specialises in thrombotic thrombocytopenic purpura (TTP), haemophilia / bleeding service and immune thrombocytopenic purpura. Her research focuses on complications of plasma exchange for TTP and thrombotic microangiopathy (TMA).

“The most rewarding part of my role at UCLH is dealing directly with my patient groups, but especially the acutely ill TTP and TMA patients”

Claire Nicholas, Lead Clinical Nurse Specialist

Claire is the lead clinical nurse specialist for haematology. She manages a team of 10 clinical nurse specialists and a Macmillan cancer support worker. She has worked as a clinical nurse specialist in a number of haematology specialties, and has a particular interest in chronic myeloid leukaemia. She is focused on providing better patient information, and is currently leading on a project which has standardised written information for newly diagnosed patients receiving care in the London Cancer hospital network.

“The most enjoyable part of my role at UCLH is leading an innovative, effective and supportive team of clinical nurse specialists. We embrace new ways of working, developing additional services and perform strongly in patient surveys”

Fran Penny, Lymphoma Clinical Nurse Specialist

Fran is one of the lead clinical nurse specialists for haematology. She manages a team of nine clinical nurse specialists, covering lymphoma and myeloma.

She has worked as a clinical nurse specialist in a number of haematology specialties, and has a particular interest in lymphoma.

“The most enjoyable part of my role is working closely with patients and their families”

Micaela Plucinski, Lymphoma Association Clinical Nurse Specialist

Micaela Plucinski

Micaela supports young adults and adults with Hodgkin and Non Hodgkin Lymphoma. She has a special interest in supporting patients at the end of treatment.

"The most rewarding aspect of my job is being there to support patients at a vulnerable time in their lives. Being able to apply my expertise and specialised knowledge to make their journey easier is why I enjoy my role."

Gemma Trout, Leukaemia Clinical Nurse Specialist

Gemma Trout

Gemma specialises in adults with acute myeloid leukaemia, acute promyloctic leukaemia and acute lymphoblastic leukaemia. She also works with mylodysplasia and aplastic anaemia patients.

“The most rewarding part of working at UCLH is the incredible multi-disciplinary team that work in haematology to provide excellent, specialist care to our patients. I have worked in the Haematology Unit since qualifying in 1998 – how long I’ve been here is a testament to the team we have here. I am challenged every single day and I learn so much from my colleagues and my patients”

Barbara von Barsewisch, Macmillan Lymphoma Clinical Nurse Specialist

Barbara von Barsewisch

Barbara specialises in lymphoma and chronic lymphocytic leukaemia (CLL), as well as HIV-related lymphomas Kaposi’s sarcoma and Castleman’s disease. Her main research interests focus on examining ways in which patients can receive a better service. These have included working on outpatient surveys and the creation of a rapid access clinic. Barbara is also on the guideline committee of the National Institute for Health and Care Excellent guidelines update “Haematological Cancers: Improving Outcomes”.

“The most rewarding part of my role at UCLH is being able to be there for patients and their families from the time of diagnosis through treatment and beyond. I take pride in supporting, educating and sharing with patients along the cancer journey, knowing that my input can help allay fears. I ensure a smooth pathway within UCLH and the community and act as a safety net for patients undergoing treatment between appointments and follow up.

Sarah Worthington, Myeloma Clinical Nurse Specialist

Sarah has worked in Haematology since 2002 and on a number of haematology wards in Manchester and London, caring for patients at all stages of their diagnosis. She worked as a bone marrow transplant co-ordinator at UCLH before 2012 when she took the role of Myeloma Clinical Nurse Specialist. In addition to myeloma, she has worked with a specialised group of Cardiac AL Amyloid patients. Sarah has also facilitated the London Myeloma Support Group for a number of years.

“Myeloma is an exciting field to work in with new developments being made. It is a privilege to be able to help people and their families through a difficult period in their lives.”

Catherine Yeomans, Clinical Nurse Specialist

Catherine Yeomans

Catherine specialises in Myeloma, Waldenströms Macroglobunaemia and other plasma cell disorders. She has specialised in haemato-oncology for eight years and completed a BSc in Haemato-oncology care.

“The most rewarding part of my role is meeting many different people at various stages of their diagnosis when they first come for treatment. With our pioneering Cancer Centre, we are able to provide patients with cutting edge treatments in a therapeutic, and holistic environment. This enables interaction with patients to be delivered in a way that is conducive to flexibility, providing an overall better experience for the patient and family”